FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track –– Enrolling approximately one patient per week ...
43m
MarketBeat on MSNWhich Healthcare Stock Is the Best Buy Right Now?In the world of upstart pharmaceuticals and healthcare companies, timing is everything. These firms often struggle for an ...
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026 MZE782 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results